Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | +4.32% | -1.36% | +116.42% |
Mar. 20 | Transcript : Trevi Therapeutics, Inc., Q4 2023 Earnings Call, Mar 20, 2024 | |
Mar. 20 | Trevi Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+116.42% | 196M | |
-2.23% | 103B | |
+1.76% | 95.28B | |
+1.46% | 22.15B | |
-15.59% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.74% | 16.05B | |
+5.12% | 13.68B | |
+35.94% | 12.17B |
- Stock Market
- Equities
- TRVI Stock
- News Trevi Therapeutics, Inc.
- JonesTrading Initiates Trevi Therapeutics at Buy With $7 Price Target